BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 12406866)

  • 1. Mitochondrial ferritin expression in erythroid cells from patients with sideroblastic anemia.
    Cazzola M; Invernizzi R; Bergamaschi G; Levi S; Corsi B; Travaglino E; Rolandi V; Biasiotto G; Drysdale J; Arosio P
    Blood; 2003 Mar; 101(5):1996-2000. PubMed ID: 12406866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant mitochondrial iron distribution and maturation arrest characterize early erythroid precursors in low-risk myelodysplastic syndromes.
    Tehranchi R; Invernizzi R; Grandien A; Zhivotovsky B; Fadeel B; Forsblom AM; Travaglino E; Samuelsson J; Hast R; Nilsson L; Cazzola M; Wibom R; Hellström-Lindberg E
    Blood; 2005 Jul; 106(1):247-53. PubMed ID: 15755901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation and Molecular Characterization of Human Ring Sideroblasts: a Key Role of Ferrous Iron in Terminal Erythroid Differentiation and Ring Sideroblast Formation.
    Saito K; Fujiwara T; Hatta S; Morita M; Ono K; Suzuki C; Fukuhara N; Onishi Y; Nakamura Y; Kawamata S; Shimizu R; Yamamoto M; Harigae H
    Mol Cell Biol; 2019 Apr; 39(7):. PubMed ID: 30670569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the iron transporter ABCB7 in refractory anemia with ring sideroblasts.
    Boultwood J; Pellagatti A; Nikpour M; Pushkaran B; Fidler C; Cattan H; Littlewood TJ; Malcovati L; Della Porta MG; Jädersten M; Killick S; Giagounidis A; Bowen D; Hellström-Lindberg E; Cazzola M; Wainscoat JS
    PLoS One; 2008 Apr; 3(4):e1970. PubMed ID: 18398482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Refractory anemia with ring sideroblasts.
    Malcovati L; Cazzola M
    Best Pract Res Clin Haematol; 2013 Dec; 26(4):377-85. PubMed ID: 24507814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and genetic characteristics of congenital sideroblastic anemia: comparison with myelodysplastic syndrome with ring sideroblast (MDS-RS).
    Ohba R; Furuyama K; Yoshida K; Fujiwara T; Fukuhara N; Onishi Y; Manabe A; Ito E; Ozawa K; Kojima S; Ogawa S; Harigae H
    Ann Hematol; 2013 Jan; 92(1):1-9. PubMed ID: 22983749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial iron metabolism and sideroblastic anemia.
    Sheftel AD; Richardson DR; Prchal J; Ponka P
    Acta Haematol; 2009; 122(2-3):120-33. PubMed ID: 19907149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome.
    Rosati S; Mick R; Xu F; Stonys E; Le Beau MM; Larson R; Vardiman JW
    Leukemia; 1996 Jan; 10(1):20-6. PubMed ID: 8558932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant splicing of genes involved in haemoglobin synthesis and impaired terminal erythroid maturation in SF3B1 mutated refractory anaemia with ring sideroblasts.
    Conte S; Katayama S; Vesterlund L; Karimi M; Dimitriou M; Jansson M; Mortera-Blanco T; Unneberg P; Papaemmanuil E; Sander B; Skoog T; Campbell P; Walfridsson J; Kere J; Hellström-Lindberg E
    Br J Haematol; 2015 Nov; 171(4):478-90. PubMed ID: 26255870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Refractory anemia with ring sideroblasts (RARS) and RARS with thrombocytosis: "2019 Update on Diagnosis, Risk-stratification, and Management".
    Patnaik MM; Tefferi A
    Am J Hematol; 2019 Apr; 94(4):475-488. PubMed ID: 30618061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sideroblasts, siderocytes, and sideroblastic anemia.
    Cartwright GE; Deiss A
    N Engl J Med; 1975 Jan; 292(4):185-93. PubMed ID: 1088923
    [No Abstract]   [Full Text] [Related]  

  • 12. Gene expression profiling of erythroblasts from refractory anaemia with ring sideroblasts (RARS) and effects of G-CSF.
    Nikpour M; Pellagatti A; Liu A; Karimi M; Malcovati L; Gogvadze V; Forsblom AM; Wainscoat JS; Cazzola M; Zhivotovsky B; Grandien A; Boultwood J; Hellström-Lindberg E
    Br J Haematol; 2010 Jun; 149(6):844-54. PubMed ID: 20408843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Causes and Pathophysiology of Acquired Sideroblastic Anemia.
    Rodriguez-Sevilla JJ; Calvo X; Arenillas L
    Genes (Basel); 2022 Aug; 13(9):. PubMed ID: 36140729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The molecular basis of the sideroblastic anemias.
    Fitzsimons EJ; May A
    Curr Opin Hematol; 1996 Mar; 3(2):167-72. PubMed ID: 9372069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment of a cell model of X-linked sideroblastic anemia using genome editing.
    Kaneko K; Kubota Y; Nomura K; Hayashimoto H; Chida T; Yoshino N; Wayama M; Ogasawara K; Nakamura Y; Tooyama I; Furuyama K
    Exp Hematol; 2018 Sep; 65():57-68.e2. PubMed ID: 29908199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microcytic anemia in a pregnant woman: beyond iron deficiency.
    Rollón N; Fernández-Jiménez MC; Moreno-Carralero MI; Murga-Fernández MJ; Morán-Jiménez MJ
    Int J Hematol; 2015 May; 101(5):514-9. PubMed ID: 25547425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleolar abnormalities--a defect of the nucleolar preribosome assembly--in ringed sideroblasts in refractory anaemia with ringed sideroblasts (RARS) of myelodysplastic syndrome (MDS). An electron microscopic study.
    Smetana K; Cermák J; Jirásková I; Malasková V
    Sb Lek; 2003; 104(2):199-207. PubMed ID: 14577129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classification of the myelodysplastic syndromes.
    Bennett JM
    Clin Haematol; 1986 Nov; 15(4):909-23. PubMed ID: 3471370
    [No Abstract]   [Full Text] [Related]  

  • 19. Congenital sideroblastic anemia model due to ALAS2 mutation is susceptible to ferroptosis.
    Ono K; Fujiwara T; Saito K; Nishizawa H; Takahashi N; Suzuki C; Ochi T; Kato H; Ishii Y; Onodera K; Ichikawa S; Fukuhara N; Onishi Y; Yokoyama H; Yamada R; Nakamura Y; Igarashi K; Harigae H
    Sci Rep; 2022 May; 12(1):9024. PubMed ID: 35637209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late-onset X-linked sideroblastic anemia. Missense mutations in the erythroid delta-aminolevulinate synthase (ALAS2) gene in two pyridoxine-responsive patients initially diagnosed with acquired refractory anemia and ringed sideroblasts.
    Cotter PD; May A; Fitzsimons EJ; Houston T; Woodcock BE; al-Sabah AI; Wong L; Bishop DF
    J Clin Invest; 1995 Oct; 96(4):2090-6. PubMed ID: 7560104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.